Registry for Lupus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on gathering and storing detailed information about Systemic Lupus Erythematosus (SLE), a disease in which the immune system attacks the body's tissues, including Lupus Nephritis, which affects the kidneys. By collecting data and biological samples, researchers aim to support future studies that could lead to better treatments. Individuals diagnosed with SLE who can follow study directions are suitable candidates for this trial. As an unphased study, this trial allows patients to contribute to foundational research that could pave the way for future breakthroughs in SLE treatment.
Why are researchers excited about this trial?
Researchers are excited about the Lupus Landmark Study because it aims to create a comprehensive registry and biorepository that could revolutionize our understanding and treatment of lupus. Unlike current treatments that primarily focus on managing symptoms with immunosuppressants or anti-inflammatory drugs, this study seeks to gather extensive data and biological samples from patients over time. By doing so, it has the potential to uncover new biomarkers, identify novel therapeutic targets, and pave the way for more personalized and effective lupus therapies in the future. This approach is significant because it shifts the focus from just treating symptoms to understanding the disease at its core, which could lead to breakthroughs in treatment strategies.
Who Is on the Research Team?
Sam Lim, MD, MPH
Principal Investigator
Emory University
Arezou Khosroshahi, MD
Principal Investigator
Emory University
Alfred Kim, MD, PhD
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enrollment
Participants are enrolled into one of four cohorts: New Onset, Active Lupus Nephritis, Extra-Renal Lupus Flare, or Prevalent Cases
Data Collection
Collection of clinical data, biospecimens, and molecular data for future research on SLE
Follow-up
Participants are monitored for safety and effectiveness after data collection
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lupus Research Alliance
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.